BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 2
• 3
• 4
• 5
• 6
• 9
• 10
• 11
• 12
• 13
• 16
• 17
• 18
• 19
• 20
• 23
• 24
• 25
• 26
• 27
• 30

• Press Releases

  Galderma’s Nemluvio® (nemolizumab) Receives National Institute for Health and Care Excellence (NICE) Recommendation for Moderate-to-severe Atopic Dermatitis in England and Wales

  June 12, 2025

   · 

  9 min read
• Press Releases

  ADC Therapeutics Announces Updated Data from LOTIS-7 Clinical Trial Presented at the European Hematology Association 2025 Congress

  June 12, 2025

   · 

  11 min read
• Press Releases

  Nurix Therapeutics Presents Updated Positive Data Demonstrating Durable, Deepening Responses in Ongoing Clinical Trial of Bexobrutideg (NX-5948) Monotherapy in Patients with Relapsed/Refractory Chronic Lymphocytic Leukemia (CLL) and Waldenström Macroglobulinemia (WM)

  June 12, 2025

   · 

  11 min read
• Press Releases

  Synthego Prevails In Patent Appeal Confirming Agilent CRISPR Patents Are Invalid

  June 12, 2025

   · 

  1 min read
• Press Releases

  Sensible Biotechnologies Slashes Time Taken to Optimize Novel Cell-Based mRNA Therapeutics by More Than 90% with AI Platform Built on NVIDIA Technology

  June 12, 2025

   · 

  2 min read
• Press Releases

  Epiminder Announces Publication of Landmark Clinical Trial Confirming Safety and Efficacy of the Minder® System

  June 12, 2025

   · 

  2 min read
• Press Releases

  Ocugen To Present at BIO International Convention 2025

  June 12, 2025

   · 

  3 min read
• Press Releases

  Juvena Therapeutics and Lilly Enter Research Collaboration Focused on Muscle Health

  June 12, 2025

   · 

  3 min read
• Press Releases

  New data show TREMFYA® (guselkumab) is the only IL-23 inhibitor proven to significantly inhibit progression of joint structural damage in active psoriatic arthritis

  June 12, 2025

   · 

  15 min read
• Press Releases

  Sunshine Biopharma Launches Generic Gabapentin for Neuropathic Pain in the Canadian Segment of the Global $1.92 Billion Market

  June 12, 2025

   · 

  4 min read